Matinas Biopharma Holdings Revenue 2012-2018 | MTNB

Matinas Biopharma Holdings revenue from 2012 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Matinas Biopharma Holdings Annual Revenue
(Millions of US $)
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
Matinas Biopharma Holdings Quarterly Revenue
(Millions of US $)
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q4 2011 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.144B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.810B 31.14
Takeda Pharmaceutical (TAK) Japan $33.231B 12.30
Grifols (GRFS) Spain $13.208B 16.01
Ionis Pharmaceuticals (IONS) United States $11.005B 34.13
Neurocrine Biosciences (NBIX) United States $7.703B 498.88
Jazz Pharmaceuticals (JAZZ) Ireland $7.671B 10.98
Sage Therapeutics (SAGE) United States $7.388B 0.00
Tilray (TLRY) United States $6.730B 0.00
Catalent (CTLT) United States $6.200B 25.96
Nektar Therapeutics (NKTR) United States $6.081B 9.70
United Therapeutics (UTHR) United States $5.196B 8.84
FibroGen (FGEN) United States $4.764B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.283B 22.76
Taro Pharmaceutical Industries (TARO) Israel $4.238B 13.64
Zogenix (ZGNX) United States $2.224B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.215B 0.00
Portola Pharmaceuticals (PTLA) United States $2.208B 0.00
PTC Therapeutics (PTCT) United States $2.149B 0.00
Aerie Pharmaceuticals (AERI) United States $2.140B 0.00
USANA Health Sciences (USNA) United States $2.129B 17.87
Ironwood Pharmaceuticals (IRWD) United States $2.072B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.994B 24.83
Endo (ENDP) Ireland $1.928B 2.97
Heron Therapeutics (HRTX) United States $1.908B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.779B 0.00
Xencor (XNCR) United States $1.712B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.625B 140.79
Corcept Therapeutics (CORT) United States $1.412B 20.52
Theravance Biopharma (TBPH) Cayman Islands $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.302B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.158B 0.00
Tricida (TCDA) United States $1.091B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.895B 0.00
Radius Health (RDUS) United States $0.860B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Forty Seven (FTSV) United States $0.559B 0.00
ChemoCentryx (CCXI) United States $0.545B 0.00
GlycoMimetics (GLYC) United States $0.541B 0.00
Dermira (DERM) United States $0.531B 0.00
ArQule (ARQL) United States $0.521B 0.00
Siga Technologies (SIGA) United States $0.490B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.486B 28.64
Akebia Therapeutics (AKBA) United States $0.466B 0.00
KalVista Pharmaceuticals (KALV) United States $0.454B 0.00
Flexion Therapeutics (FLXN) United States $0.453B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Translate Bio (TBIO) United States $0.434B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 0.00
TCR2 THERAPTCS (TCRR) United States $0.419B 0.00
Concert Pharmaceuticals (CNCE) United States $0.395B 0.00
ImmunoGen (IMGN) United States $0.387B 0.00
Aptorum Group (APM) China $0.378B 0.00
OptiNose (OPTN) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Karyopharm Therapeutics (KPTI) United States $0.323B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.316B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.316B 0.00
CASI Pharmaceuticals (CASI) United States $0.314B 0.00
Lannett Co Inc (LCI) United States $0.310B 2.88
HARPOON THERAPT (HARP) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.292B 0.00
Majesco Entertainment (PTE) United States $0.283B 0.00
Immune Design (IMDZ) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.278B 0.00
Xeris Pharmaceuticals (XERS) United States $0.277B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.274B 10.14
MARKER THERAPEUTICS, INC (MRKR) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.256B 0.00
Dova Pharmaceuticals (DOVA) United States $0.253B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.250B 0.00
Affimed (AFMD) Germany $0.245B 0.00
Tyme Technologies (TYME) United States $0.242B 0.00
ElectroCore (ECOR) United States $0.235B 0.00
Opexa Therapeutics (ACER) United States $0.235B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.218B 0.00
Aldeyra Therapeutics (ALDX) United States $0.217B 0.00
MEI Pharma (MEIP) United States $0.214B 0.00
IMV INC (IMV) Canada $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
Recro Pharma (REPH) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.194B 201.80
Aratana Therapeutics (PETX) United States $0.187B 0.00
Redhill Biopharma (RDHL) Israel $0.186B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Rafael Holdings (RFL) United States $0.182B 0.00
Ocular Therapeutix (OCUL) United States $0.174B 0.00
Aquestive Therapeutics (AQST) United States $0.172B 0.00
Neon Therapeutics (NTGN) United States $0.165B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.158B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
Cardiome Pharma (CORV) Canada $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
MediWound (MDWD) Israel $0.138B 0.00
ProNAi Therapeutics (SRRA) Canada $0.138B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.124B 0.00
DURECT (DRRX) United States $0.122B 0.00
Champions Oncology (CSBR) United States $0.122B 0.00
Zafgen (ZFGN) United States $0.114B 0.00
Adherex Technologies (FENC) United States $0.113B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.113B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Nivalis Therapeutics (ALPN) United States $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
India Globalization Capital (IGC) United States $0.089B 0.00
Otonomy (OTIC) United States $0.089B 0.00
Natural Alternatives (NAII) United States $0.085B 8.34
Genocea Biosciences (GNCA) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.079B 0.00
Iterum Therapeutics (ITRM) Ireland $0.078B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.073B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.072B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.069B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.063B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Capnia (SLNO) United States $0.055B 0.00
KemPharm (KMPH) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Lipocine (LPCN) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.037B 0.00
Achaogen (AKAO) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.033B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
ContraFect (CFRX) United States $0.030B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Shineco (TYHT) China $0.015B 2.54
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00